Selected Topics: Neurological Emergencies| Volume 57, ISSUE 2, P212-215, August 2019

Ultrasound-Assisted Diagnosis of Optic Neuritis in the Emergency Department: A Case Report



      Optic neuritis is a common cause of subacute unilateral vision loss, occurring in 1–5 per 100,000 persons per year. It is more common in Caucasians, women, and those from countries with northern latitudes. Those aged 20–49 years are at greatest risk. The condition arises due to inflammation of the optic nerve. Inflammation may occur due to systemic inflammatory disorders, most commonly multiple sclerosis.

      Case Report

      A 21-year-old African-American male presented to our emergency department with a complaint of painful unilateral vision loss. On examination he was found to have a relative afferent pupillary defect and red desaturation. A bedside ultrasound suggested pseudopapilledema suggestive of optic neuritis. He was admitted to Neurology for confirmation of and treatment for optic neuritis. Magnetic resonance imaging confirmed optic neuritis. The patient was treated with i.v. steroids and discharged after improvement in visual function.

      Why Should an Emergency Physician Be Aware of This?

      Optic neuritis is a clinical diagnosis. The subtle historical components and examination findings make it a diagnostic challenge for the busy emergency physician. Early diagnosis may improve visual outcomes. Discovery of pseudopapilledema on bedside ultrasound may be seen in optic neuritis, and is another finding that emergency physicians may assess for in patient presenting with unilateral vision loss.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hickman S.
        • Dalton C.
        • Miller D.
        • Plant G.
        Management of acute optic neuritis.
        Lancet. 2002; 360: 1953-1962
        • Balcer L.J.
        Optic neuritis.
        N Engl J Med. 2006; 354: 1273-1280
        • American Academy of Ophthalmology
        Color vision.
        (Available at:)
        • Barker G.J.
        Technical issues for the study of the optic nerve with MRI.
        J Neurol Sci. 2000; 172: S13
        • Mehrpour M.
        • Torshizi F.O.
        • Esmaeeli S.
        • Taghipour S.
        • Abdollahi S.
        Optic nerve sonography in the diagnostic evaluation of pseudopapilledema and raised intracranial pressure: a cross-sectional study.
        Neurol Res Int. 2015; 2015: 146059
        • Beck R.W.
        • Cleary P.A.
        • Anderson Jr., M.M.
        • et al.
        A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
        N Engl J Med. 1992; 326: 581-588
        • Beck R.W.
        • Gal R.L.
        • Bhatti M.T.
        • et al.
        Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.
        Am J Ophthalmol. 2004; 137: 77-83
        • Beck R.W.
        • Trobe J.D.
        • Moke P.S.
        • et al.
        High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
        Arch Ophthalmol. 2003; 121: 944-949
      1. The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Optic neuritis study group.
        Arch Ophthalmol. 1991; 109: 1673-1678
        • Brusa A.
        • Jones S.J.
        • Plant G.T.
        Long-term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study.
        Brain. 2001; 124: 468-479
        • Optic Neuritis Study Group
        The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.
        Neurology. 1997; 49: 1404-1413